Management of idiopathic membranous nephropathy

Claudio Ponticelli, Patrizia Passerini

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Importance of the field: Idiopathic membranous nephropathy (IMN) can have a variable natural course. Treatments able to induce remission can improve the long-term prognosis. However, the optimal therapy for IMN remains controversial. Area covered in this review: We reviewed the historical and current literature from 1979 to 2010 regarding the natural course of IMN and the possible treatments giving special emphasis to randomized controlled trials and to more recent approaches. What the reader will gain: The reader will gain a comprehensive review of the available treatments of IMN. A personal therapeutic algorithm for nephrotic patients with IMN is also provided. Take home message: At least five different treatments showed efficacy in many (but not all) patients with IMN.

Original languageEnglish
Pages (from-to)2163-2175
Number of pages13
JournalExpert Opinion on Pharmacotherapy
Volume11
Issue number13
DOIs
Publication statusPublished - Sep 2010

Fingerprint

Membranous Glomerulonephritis
Therapeutics
Randomized Controlled Trials

Keywords

  • Glomerulonephritis
  • Immunosuppressive therapy
  • Membranous nephropathy
  • Nephrotic syndrome

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Management of idiopathic membranous nephropathy. / Ponticelli, Claudio; Passerini, Patrizia.

In: Expert Opinion on Pharmacotherapy, Vol. 11, No. 13, 09.2010, p. 2163-2175.

Research output: Contribution to journalArticle

Ponticelli, Claudio ; Passerini, Patrizia. / Management of idiopathic membranous nephropathy. In: Expert Opinion on Pharmacotherapy. 2010 ; Vol. 11, No. 13. pp. 2163-2175.
@article{ebee8f54b4a94d9eba06b18ffd2e0bba,
title = "Management of idiopathic membranous nephropathy",
abstract = "Importance of the field: Idiopathic membranous nephropathy (IMN) can have a variable natural course. Treatments able to induce remission can improve the long-term prognosis. However, the optimal therapy for IMN remains controversial. Area covered in this review: We reviewed the historical and current literature from 1979 to 2010 regarding the natural course of IMN and the possible treatments giving special emphasis to randomized controlled trials and to more recent approaches. What the reader will gain: The reader will gain a comprehensive review of the available treatments of IMN. A personal therapeutic algorithm for nephrotic patients with IMN is also provided. Take home message: At least five different treatments showed efficacy in many (but not all) patients with IMN.",
keywords = "Glomerulonephritis, Immunosuppressive therapy, Membranous nephropathy, Nephrotic syndrome",
author = "Claudio Ponticelli and Patrizia Passerini",
year = "2010",
month = "9",
doi = "10.1517/14656566.2010.494599",
language = "English",
volume = "11",
pages = "2163--2175",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Taylor and Francis Ltd.",
number = "13",

}

TY - JOUR

T1 - Management of idiopathic membranous nephropathy

AU - Ponticelli, Claudio

AU - Passerini, Patrizia

PY - 2010/9

Y1 - 2010/9

N2 - Importance of the field: Idiopathic membranous nephropathy (IMN) can have a variable natural course. Treatments able to induce remission can improve the long-term prognosis. However, the optimal therapy for IMN remains controversial. Area covered in this review: We reviewed the historical and current literature from 1979 to 2010 regarding the natural course of IMN and the possible treatments giving special emphasis to randomized controlled trials and to more recent approaches. What the reader will gain: The reader will gain a comprehensive review of the available treatments of IMN. A personal therapeutic algorithm for nephrotic patients with IMN is also provided. Take home message: At least five different treatments showed efficacy in many (but not all) patients with IMN.

AB - Importance of the field: Idiopathic membranous nephropathy (IMN) can have a variable natural course. Treatments able to induce remission can improve the long-term prognosis. However, the optimal therapy for IMN remains controversial. Area covered in this review: We reviewed the historical and current literature from 1979 to 2010 regarding the natural course of IMN and the possible treatments giving special emphasis to randomized controlled trials and to more recent approaches. What the reader will gain: The reader will gain a comprehensive review of the available treatments of IMN. A personal therapeutic algorithm for nephrotic patients with IMN is also provided. Take home message: At least five different treatments showed efficacy in many (but not all) patients with IMN.

KW - Glomerulonephritis

KW - Immunosuppressive therapy

KW - Membranous nephropathy

KW - Nephrotic syndrome

UR - http://www.scopus.com/inward/record.url?scp=77955816666&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955816666&partnerID=8YFLogxK

U2 - 10.1517/14656566.2010.494599

DO - 10.1517/14656566.2010.494599

M3 - Article

C2 - 20707756

AN - SCOPUS:77955816666

VL - 11

SP - 2163

EP - 2175

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 13

ER -